๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical utility of her-2/NEU amplification as a prognostic indicator in patients with breast cancer

โœ Scribed by S.A. Cross; M.C. Lowery; C.G. Sciotto

Book ID
114136683
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
137 KB
Volume
98
Category
Article
ISSN
0165-4608

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Clinical Utility of Serum HER2/neu in Br
Clinical Utility of Serum HER2/neu in Breast Cancer
โœ G. Kesava Reddy; Vinay K. Jain; Kim Leitzel; Joyce A. O'Shaughnessy ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› CIG Media Group, LP. ๐ŸŒ English โš– 99 KB
The relative prognostic significance of
The relative prognostic significance of total cathepsin D and HER-2/neu oncogene amplification in breast cancer
โœ Ram Seshadri; David J. Horsfall; Frank Firgaira; Kieran McCaul; Vittal Setlur; A ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 536 KB

Total tumor cathepsin D (TCD) levels were determined prospectively by a radioimmunometric assay in tumor c y t o d of 858 primary breast cancer patients diagnosed between 1989-1991. In 581 of these patients, tumor HER-l/neu oncogene amplification was simultaneously determined. In a "traininset" of 3